Introduction
============

Various factors have been known to control gene expression and form a complex regulatory network. Regulation of gene expression is strongly associated with the maintenance of normal cells and a variety of biological functions. The most prominent gene regulators are DNA methylation, transcription factor (TF), and microRNA (miRNA), which regulate gene expression at the pretranscriptional, transcriptional, and posttranscriptional levels, respectively. DNA methylation is a heritable epigenetic marker that regulates gene expression without altering DNA sequence ([@evu124-B21]). This modification is highly associated with many cellular processes, including transcription, genomic imprinting, suppression of transposons, X-chromosome inactivation, chromatin structure, embryonic development, and carcinogenesis ([@evu124-B44]; [@evu124-B29]; [@evu124-B76]; [@evu124-B62]; [@evu124-B24]; [@evu124-B42]). Several studies have indicated that promoter methylation and gene body methylation exhibit different correlation patterns with gene expression. Promoter methylation is generally associated with transcriptional suppression, whereas gene body methylation is associated with active transcription ([@evu124-B37]; [@evu124-B30]; [@evu124-B2]; [@evu124-B8]; [@evu124-B50]; [@evu124-B25]; [@evu124-B42]; [@evu124-B54]; [@evu124-B80]; [@evu124-B84]; [@evu124-B20]; [@evu124-B36]); therefore, methylation in promoter and gene body regions may play distinct biological roles.

As for the two *trans*-regulatory factors (TFs and miRNAs), TFs are proteins that bind to specific DNA sequences (so-called "TF binding sites" \[TFBSs\]) usually located within promoters, through which they facilitate or repress the transcription of their target genes ([@evu124-B23]; [@evu124-B75]); on the other hand, miRNAs are small (∼22 nt) noncoding RNAs that target mRNAs and regulate gene expression through mRNA cleavage or translation repression ([@evu124-B3], [@evu124-B4]). It has been reported that miRNAs can form intricate feedback and feed-forward loops with TFs within the context of gene regulatory networks ([@evu124-B33]; [@evu124-B65]; [@evu124-B74]; [@evu124-B68]). Such miRNA--TF networks are important for the stability of gene regulation mechanisms ([@evu124-B65]; [@evu124-B83]), and may play crucial roles in diverse biological processes ([@evu124-B53]; [@evu124-B19]). In contrast, interactions between these two *trans*-regulatory factors (i.e., TFs and miRNAs) and DNA methylation during gene regulation are relatively poorly understood.

In terms of molecular evolution, DNA methylation has been reported to remarkably increase the rate of spontaneous C-to-T mutations at CpG dinucleotides ([@evu124-B22]; [@evu124-B35]; [@evu124-B56]), resulting in enhanced sequence divergence. On the other hand, it has been recently reported that hypermethylated genes are subject to stronger selective constraints than hypomethylated genes ([@evu124-B34]; [@evu124-B51]; [@evu124-B58]; [@evu124-B64]; [@evu124-B73]). We previously observed that the first exons of transcripts are more susceptible to mutagenic effects, whereas the internal and last exons are more affected by the regulatory effects of DNA methylation ([@evu124-B17]). We further indicated that the extent of gene body methylation correlates highly with within-gene variations (e.g., the type of exonic sequences, relative genic position, and degeneracy of coding nucleotides) in evolutionary rates at both the exon and nucleotide levels ([@evu124-B17]; [@evu124-B16]). On the other hand, the evolutionary effects of TFs and miRNAs have been carefully examined, revealing that genes targeted by more different TFs (number of different TFs designated as "*N*~TF~") or miRNAs (number of different miRNAs designated as "*N*~miR~") tend to evolve more slowly in diverse species ([@evu124-B14]; [@evu124-B79]; [@evu124-B77]; [@evu124-B11]; [@evu124-B13]). These results manifested that all these regulatory factors are important indicators of evolutionary rates, regardless of DNA methylation at the pretranscriptional level, TF regulation at the transcriptional level, or miRNA regulation at the posttranscriptional level. However, to the best of our knowledge, no systematic evolutionary analysis is currently available that simultaneously accounts for these three regulatory factors. The following questions still await exploration: whether promoter and gene body methylation differentially correlated with the evolutionary rates of their target genes, *N*~TF~, and *N*~miR~; which of these factors has a greater effect on the rate of mammalian protein evolution; and whether DNA methylation and *trans*-regulations have an interactive influence on protein evolutionary rates.

In this study, we collected single base-resolution DNA methylation data and TF- and miRNA-binding data from human, and systematically examined the correlations between these regulatory factors (i.e., levels of promoter/gene body methylation, *N*~TF~, and *N*~miR~) and the evolutionary rates of their target genes (nonsynonymous substitution rate \[*d*~N~\], synonymous substitution rate \[*d*~S~\], and *d*~N~/*d*~S~ ratio). To control for other confounding factors that may affect the evolutionary rates of protein-coding genes, we also considered the following eight biological factors in our statistical analyses: 1) Protein connectivity ([@evu124-B43]; [@evu124-B61]; [@evu124-B79]; [@evu124-B47]; [@evu124-B77]); 2) gene expression level ([@evu124-B46], [@evu124-B47]; [@evu124-B41]; [@evu124-B79]; [@evu124-B11]; [@evu124-B82]); 3) tissue-specific gene expression ([@evu124-B46], [@evu124-B47]; [@evu124-B41]; [@evu124-B60]; [@evu124-B82]); gene compactness in terms of 4) untranslated region (UTR) length ([@evu124-B46]; [@evu124-B14]; [@evu124-B82]), 5) intron length ([@evu124-B52]; [@evu124-B46], [@evu124-B47]; [@evu124-B82]), and 6) intron number ([@evu124-B41]; [@evu124-B82]); and protein structure in terms of 7) solvent accessibility ([@evu124-B7]; [@evu124-B49]; [@evu124-B86]; [@evu124-B26]) and 8) disorder content ([@evu124-B38]; [@evu124-B9]; [@evu124-B11]). In this way, we show that the levels of DNA methylation of both promoters and gene bodies are important indicators of protein evolutionary rates (*d*~N~ and *d*~N~/*d*~S~) when other confounding factors are controlled. Interestingly, protein evolutionary rates are positively correlated with the level of promoter methylation, but negatively correlated with the level of gene body methylation. Furthermore, promoter methylation is negatively correlated with *N*~TF~ and *N*~miR~, whereas gene body methylation is positively correlated with the two *trans*-regulations. We also report that the level of promoter methylation and *N*~miR~ have the greatest influence on protein evolutionary rates, and they have a dependent effect on the rate of mammalian protein evolution. This result supports the previously hypothesized potential reciprocal regulation between these two regulatory factors ([@evu124-B71], [@evu124-B72]).

Materials and Methods
=====================

Collection of Single Base-Resolution DNA Methylation, TFBS, and miRNA Target Data
---------------------------------------------------------------------------------

The human gene annotations, gene orthology assignments, and human--mouse/human--rhesus macaque evolutionary rates (*d*~N~, *d*~S~, and *d*~N~/*d*~S~) were downloaded from the Ensembl database at <http://www.ensembl.org/> (last accessed November 2013) (version 73). We considered only 1:1 human--mouse and human--rhesus macaque orthologs to avoid the confounding factor of gene duplication; furthermore, we considered only the longest isoforms of alternatively spliced genes. The promoter region of a gene was defined as the intergenic region from 8 kb upstream to 2 kb downstream of the Ensemble-annotated gene start position. Genes with genic regions (including exons and introns) ≤2 kb in length were not considered. For accuracy, a gene whose promoter region overlaps with other gene(s) was not considered. The base-resolution DNA methylation data from 12 human cell types (including cultured cells, cells from healthy individuals \[S1--S11, [table 1](#evu124-T1){ref-type="table"}\], and breast cancer cells \[[supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online\]) were downloaded from NGSmethDB v2 ([@evu124-B28]) at <http://bioinfo2.ugr.es/NGSmethDB/> (last accessed October 2013). These data sets were generated with bisulfite or MethylC sequencing. CpG dinucleotides with single nucleotide variants were not considered in this study to avoid potential sequencing errors. To ensure the accuracy of the methylome data, only CpG dinucleotides covered by ≥5 bisulfite/MethylC reads were considered (such CpG dinucleotides were designated as "sampled CpGs"). A sampled CpG site is regarded as methylated (designated as "mCG") if ≥80% of the mapped reads support the methylation status at the CpG site ([@evu124-B55]; [@evu124-B42]). We only considered the genes whose promoter and gene body regions both contained ≥10 sampled CpGs to ensure that the examined regions contained sufficient information for estimating the methylation level. Of note, the gene body region of a gene represents the coding sequence, with the exception of regions overlapping with the promoter of the gene (e.g., 2 kb downstream of the Ensemble-annotated gene start position). Table 1Experimentally Determined Single Base-Resolution DNA Methylation Data Used in this StudySampleDescription (Ref.)No. of Genes (Sampled \#CG ≥ 10)Average CpG Coverage[^a^](#evu124-TF1){ref-type="table-fn"} (Promoter) (%)Average CpG Coverage[^a^](#evu124-TF1){ref-type="table-fn"} (Gene Body) (%)S1Peripheral blood B lymphocytes ([@evu124-B31])10,62776.0486.69S2Peripheral blood hematopoietic stem/progenitor cells (CD133+CD34+CD38−Lin−) ([@evu124-B31])10,45178.0389.10S3Newborn foreskin fibroblasts ([@evu124-B42])10,38889.3493.56S4H1 embryonic stem cells ([@evu124-B50])10,75168.5489.41S5Breast cells from adult female ([@evu124-B32])10,91696.7898.75S6Peripheral blood hematopoietic stem/progenitor cells (CD34+CD38−Lin−) ([@evu124-B31])10,72280.0489.41S7Fetal lung fibroblasts ([@evu124-B50])10,84878.1393.62S8Peripheral blood granulocytic neutrophils ([@evu124-B31])10,08171.2782.91S9Prefrontal cortex ([@evu124-B85])10,55680.5890.38S10H9 embryonic stem cells ([@evu124-B42])10,52291.8195.31S11Fibroblasts derived from H9 embryonic stem cells ([@evu124-B42])10,43690.0193.65[^2]

TFBS data were obtained by downloading chromatin immunoprecipitation (ChIP) data (which includes 162 human TF ChIP-seq data sets) from the ENCODE project ([@evu124-B5]). A given TF was considered to regulate a gene if at least one of its ChIP-seq peaks was located within the promoter region of the gene. Human miRNA target prediction data (which include 1,267 miRNAs) were downloaded from TargetScan release 6.2 (April 2013) ([@evu124-B63]; [@evu124-B27]). For accuracy, we only considered the human miRNA families in which the corresponding target sites were determined to be conserved across mammals using TargetScan ([@evu124-B27]). The human, rhesus macaque, and mouse genes examined in this study (together with the related information) are available at <http://idv.sinica.edu.tw/trees/DM_TF_miRNA/DM_TF_miRNA.html> (last accessed June 25, 2014).

Measurement of CpG Dinucleotide Depletion (CpG~O/E~) and the Methylation Level in Promoter and Gene Body Regions
----------------------------------------------------------------------------------------------------------------

Since a low ratio of observed-to-expected CpG dinucleotides (CpG~O/E~) represents a large fraction of mutated CpG dinucleotides, CpG~O/E~ is a measurement of CpG dinucleotide depletion ([@evu124-B6]; [@evu124-B58], [@evu124-B59]). CpG~O/E~ was defined as follows: $$\begin{array}{l}
{\text{CpG}_{\text{O/E}} = \frac{P_{\text{CpG}}}{P_{\text{C}} \times P_{\text{G}}} =} \\
{\frac{\text{number
of\ CpGs} \times \text{length\ of\ the
examined\ region}}{\text{number\ of
Cs} \times \text{number\ of
Gs}},} \\
\end{array}$$ where *P*~CpG~, *P*~C~, and *P*~G~ represent the frequency of CpG dinucleotides, C nucleotides, and G nucleotides, respectively, in the examined promoter/gene body regions. The methylation level of an examined region was measured by calculating the density of mCG per 100 CpG dinucleotides (mCG density). mCG density was defined as $$\text{mCG
density} = \frac{\text{number
of
mCGs} \times \text{100}}{\text{number
of\ all\ CpGs
sampled}}.$$

Data Retrieval of Protein Connectivity, Gene Expression, Gene Compactness, and Protein Structural Features
----------------------------------------------------------------------------------------------------------

Protein connectivity (PPI) data were downloaded from STRING 9.0 ([@evu124-B70]). Gene expression data were obtained by downloading normalized expression data sets for 78 nonpathogenic human tissues from BioGPS ([@evu124-B78]). If more than one probe set referred to the same gene, the signals from the relevant probe sets were averaged. The gene expression level was defined as the average signal intensity across the 78 examined tissues. The tissue specificity (*τ*) of a gene was defined as follows: $$\tau = \frac{\sum_{i = 1}^{n}\left( {1 - \frac{\log S(i)}{\log S_{\max}}} \right)}{n - 1},$$ where *n*, *S*(*i*), and *S*~max~ denote the number of examined tissues (i.e., *n* = 78), the signal intensity, and the highest signal across all examined tissues, respectively ([@evu124-B81]). A large *τ* value indicates high tissue specificity for a gene. To minimize potential noise that might be caused by low signal intensities, values of *S*(*i*) less than 100 were set to 100 ([@evu124-B48]; [@evu124-B46]; [@evu124-B10]). Gene compactness was described based on intron number and average length of UTR/intron for a given gene. Protein structure was described based on solvent accessibility and disorder content. The solvent accessibility of a protein was calculated from the maximum number of exposed residues interacting with solvent molecules over the protein's length; the exposed residues were determined using ACCPro release 4.1 with the default parameters ([@evu124-B15]). Only proteins \<8,000 amino acids in length were considered due to limitations of ACCPro ([@evu124-B15]). The disorder content of a protein was defined as the percentage of intrinsically disordered regions, estimated by dividing the number of disordered residues by protein length. The disordered residues were predicted using DISOPRED2 version 2.4 with default parameters ([@evu124-B1]). To minimize the standard error when calculating disorder content, we only considered proteins ≥100 amino acids in length ([@evu124-B11]).

Calculation of the Relative Contribution to Variability Explained
-----------------------------------------------------------------

The relative contribution to variability explained (RCVE) is used to assess the relative importance of each tested factor, which is defined as follows: $$\text{RCVE} = \frac{R_{\text{full}}^{2} - R_{\text{reduced}}^{2}}{R_{\text{full}}^{2}},$$ where $R_{\text{full}}^{2}$ and $R_{\text{reduced}}^{2}$ denote the *R*^2^ value (share of variability explained) of the full model (including all of the tested factors) and that of the reduced model (excluding the factor of interest), respectively. *R*^2^ is the square of the coefficient of correlation between the observations and their predicted values in a multiple linear regression model, which is a measure of the proportion of total variation of observed outcomes explained by the model. Accordingly, the RCVE coefficient represents the relative contribution of a factor in the context of all other factors included in the full model, which ranges from 0 to 1 with a higher value indicating a more important contribution of the factor of interest to the regression model ([@evu124-B40]).

Results and Discussion
======================

Promoter and Gene Body Methylation Exhibit Opposite Correlation Patterns with the Protein Evolutionary Rates of Their Target Genes
----------------------------------------------------------------------------------------------------------------------------------

To investigate the levels of DNA methylation in human promoter and gene body regions, we retrieved single base-resolution DNA methylation data from 11 human cell lines (see Materials and Methods; [table 1](#evu124-T1){ref-type="table"}). It should be noted that the gene body regions examined were coding sequences, with the exception of regions overlapping with the promoter regions. [Table 1](#evu124-T1){ref-type="table"} shows the number of genes examined in each data set. The level of DNA methylation was measured by the density of mCG (see Materials and Methods). For each gene considered, both the examined promoter and gene body regions contained at least 10 sampled CpGs (see Materials and Methods). On average, over 68% of CpGs were sampled for both examined promoters and gene bodies ([table 1](#evu124-T1){ref-type="table"}), indicating that sufficient CpG dinucleotides were sampled in the examined regions.

To probe the impact of promoter and gene body methylation on evolution, we first examined the correlation between CpG~O/E~ (i.e., the ratio of the observed-to-expected number of CpG dinucleotides, see Materials and Methods) and promoter/gene body mCG density. Low CpG~O/E~ ratios (indicating a high level of C-to-T mutations) have been reported to be caused primarily by DNA methylation ([@evu124-B6]; [@evu124-B58], [@evu124-B59]); therefore, an inverse correlation is observed between CpG~O/E~ and DNA methylation ([@evu124-B6]; [@evu124-B84]; [@evu124-B58]). As such, the coefficient of correlation between these two measurements can be used to estimate the proportion of methylated CpGs that have undergone mutation ([@evu124-B17]). As shown in [figure 1](#evu124-F1){ref-type="fig"}, both promoter and gene body mCG densities were generally negatively correlated with CpG~O/E~. Meanwhile, the absolute values of the Spearman's rank correlation coefficient (*ρ*) between CpG~O/E~ and mCG densities were observed to be generally higher in promoters than in gene bodies ([fig. 1](#evu124-F1){ref-type="fig"}), suggesting that promoter regions are more susceptible to the mutagenic effect of DNA methylation than gene bodies. This result also echoes our earlier report that DNA methylation tends to more easily induce C-to-T mutations in the first exons than in internal/last exons ([@evu124-B17]), and implies differential evolutionary effects of promoter and gene body methylation. F[ig]{.smallcaps}. 1.---Spearman's rank correlation coefficient (*ρ*) between CpG~O/E~ and mCG density for the promoter and gene body regions in the 11 analyzed methylomes. \**P* \< 0.05 and \*\*\**P* \< 0.001. F[ig]{.smallcaps}. 2.---Spearman's rank correlation coefficient (*ρ*) between average promoter/gene body mCG densities for the 11 analyzed samples ([table 1](#evu124-T1){ref-type="table"}) and the 2 regulatory factors (*N*~TF~ or *N*~miR~) (*A*) before and (*B*) after controlling for 10 other confounding factors (see text). The analyses were based on 5,418 genes containing all confounding factors examined. \*\*\**P* \< 0.001.

We next examined whether promoter and gene body methylation levels are differentially correlated with the evolutionary rates (*d*~N~, *d*~S~, and *d*~N~/*d*~S~) of their target genes. Here, we examined the level of methylation using the average mCG density across the 11 methylomes in [table 1](#evu124-T1){ref-type="table"}. As shown in [table 2](#evu124-T2){ref-type="table"}, the *d*~N~, *d*~S~, and *d*~N~/*d*~S~ values of target genes are all positively correlated with average mCG density in promoters, but negatively correlated with that in gene bodies, for both human--macaque and human--mouse comparisons (all *P* values \<10^−7^). This result reveals that DNA methylation levels of promoters and gene bodies have opposite effects on the evolutionary rates of their target genes. To control for other confounding factors that may affect the evolutionary rates of protein-coding genes, we used partial correlation analyses ([@evu124-B39]) to simultaneously control for gene body (or promoter) mCG density, *trans*-regulation (*N*~TF~ and *N*~miR~), and eight other confounding factors as stated in Introduction section: Protein connectivity, gene expression (level and tissue specificity), gene compactness (UTR length, intron length, and intron number), and protein structure (solvent accessibility and disorder content). We found that protein evolutionary rates (*d*~N~ and *d*~N~/*d*~S~ values) remain positively correlated with promoter methylation level and negatively correlated with gene body methylation level ([table 2](#evu124-T2){ref-type="table"}). The results thus indicate that both promoter and gene body methylation levels are important indicators of protein evolutionary rates, even though the evolutionary effect of gene body methylation is more influenced by the aforementioned confounding factors than that of promoter methylation. Of interest, the partial correlation between gene body methylation level and *d*~S~ disappears or even becomes positive after the control ([table 2](#evu124-T2){ref-type="table"}), suggesting that highly methylated regions are subject to strong selective pressure at the protein level despite the enhanced mutation rate (resulting in elevated *d*~S~) in gene bodies. Moreover, the absolute correlation coefficient value for promoter mCG density is greater than that for gene body mCG density after the control ([table 2](#evu124-T2){ref-type="table"}). This indicates that *d*~N~ and *d*~N~/*d*~S~ are more strongly correlated with promoter mCG density than with gene body mCG density. We thus suggest that the rate of mammalian protein evolution may be influenced more by promoter methylation than by gene body methylation. Furthermore, we also examined the correlation between protein evolutionary rates and gene promoter/gene body mCG density in turn by controlling for each of the abovementioned confounding factors. The trends that protein evolutionary rates are positively correlated with promoter methylation level and negatively correlated with gene body methylation level are generally maintained ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online). The absolute correlation coefficient values also indicate that the correlations between protein evolutionary rates and promoter/gene body methylation levels are greatly influenced by *N*~TF~ and *N*~miR~, although all the correlations remain significant ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online). Table 2Spearman's Rank Correlation Coefficient (*ρ*) between Promoter (or Gene Body) mCG Density and the Evolutionary Rates (*d*~N~, *d*~S~, and *d*~N~/*d*~S~) for Human--Macaque and Human--Mouse Comparisons Before and After Controlling for Gene Body (or Promoter) mCG Density and Ten Other Confounding Factors**Before ControlAfter Control***d*~N~*d*~S~*d*~N~*/d*~S~*d*~N~*d*~S~*d*~N~*/d*~S~Human--macaque[^a^](#evu124-TF3){ref-type="table-fn"}    Promoter methylation0.2052\*\*\*0.0798\*\*\*0.1928\*\*\*0.1434\*\*\*0.00090.1601\*\*\*    Gene body methylation−0.0975\*\*\*−0.0872\*\*\*−0.0803\*\*\*−0.0607\*\*\*−0.0121−0.0718\*\*\*Human--mouse[^b^](#evu124-TF4){ref-type="table-fn"}    Promoter methylation0.268\*\*\*0.1453\*\*\*0.2304\*\*\*0.1907\*\*\*0.0329[\*](#evu124-TF5){ref-type="table-fn"}0.1827\*\*\*    Gene body methylation−0.096\*\*\*−0.0768\*\*\*−0.0793\*\*\*−0.0289[\*](#evu124-TF5){ref-type="table-fn"}0.025−0.0452\*\*\*[^3][^4][^5][^6]

Promoter and Gene Body Methylation Levels Exhibit Different Correlation Patterns with TF/miRNA Regulations
----------------------------------------------------------------------------------------------------------

We proceeded to investigate the relationships between DNA methylation in promoter/gene body regions and the two *trans*-regulations (*N*~TF~ and *N*~miR~); Spearman's correlation analyses revealed that *N*~TF~ and *N*~miR~ both exhibit a negative correlation with promoter mCG density, but a positive correlation with gene body mCG density (all *P* values \<10^−8^; [fig. 2](#evu124-F2){ref-type="fig"}*A*). Because *N*~TF~ and *N*~miR~ may also be correlated with other confounding factors as stated in the last section, we in turn performed partial correlation between one of the promoter/gene body mCG densities and one of the two *trans-*regulations (*N*~TF~ or *N*~miR~) by simultaneously controlling for two other factors and the eight abovementioned confounding factors ([fig. 2](#evu124-F2){ref-type="fig"}*B*). After the control, we found that *N*~TF~ and *N*~miR~ still exhibit a negative correlation with promoter mCG density, and *N*~TF~ remains positively correlated with gene body mCG density, whereas the partial correlation between *N*~miR~ and gene body mCG density disappears ([fig. 2](#evu124-F2){ref-type="fig"}*B*). This suggests that the correlation between *N*~miR~ and gene body methylation is greatly influenced by other confounding factors. In addition, the absolute correlation coefficient values also suggest that both promoter and gene body mCG densities are more strongly correlated with *N*~TF~ than with *N*~miR~.

Regarding promoter methylation, it was previously reported that the interactions between TFBSs and their corresponding TFs are sensitive to DNA methylation ([@evu124-B11]), and TFBSs tend to be hypomethylated to prevent destabilization of TF--DNA interactions ([@evu124-B66]; [@evu124-B50]; [@evu124-B67]). In addition, it has been suggested that promoter methylation and miRNA regulation may complement each other's function, and thus the promoters of genes regulated by more miRNAs tend to have a lower level of DNA methylation ([@evu124-B69]). These interconnections between biological features may lead to such a negative correlation between promoter mCG density and theses two *trans-*regulations.

Regarding gene body methylation, body-methylated genes have been suggested to be functional important and represent housekeeping functions ([@evu124-B64]; [@evu124-B73]). Densely methylated genes tend to evolve more slowly than sparsely methylated genes ([@evu124-B34]; [@evu124-B51]; [@evu124-B58]; [@evu124-B64]; [@evu124-B73]). These observations indicate a negative correlation between gene body methylation and protein evolutionary rates (*d*~N~ and *d*~N~/*d*~S~). As for TF/miRNA regulations, genes targeted by more TFs or miRNAs tend to be under stronger selective constraints ([@evu124-B14]; [@evu124-B79]; [@evu124-B77]; [@evu124-B11]). Such a trend is broadly maintained throughout metazoa ([@evu124-B13]). Thus, both *N*~TF~ and *N*~miR~ are negatively correlated with protein evolutionary rates. In addition, a positive correlation was observed between *N*~TF~ and *N*~miR~ ([@evu124-B18]; [@evu124-B13]). These findings thus reveal that these three factors (gene body mCG density, *N*~TF~, and *N*~miR~) are all negatively correlated with *d*~N~ and *d*~N~/*d*~S~, implying a positive correlation between gene body mCG density and *trans-*regulations.

Taken together, the trend that promoter and gene body methylation levels have different correlation patterns with the two *trans*-regulations (*N*~TF~ and *N*~miR~) also reflects the different effects of promoter and gene body methylation on the protein evolutionary rates of target genes ([table 2](#evu124-T2){ref-type="table"}). This also implies the existence of a complicated interaction between these two *trans*-regulations and DNA methylation in different regions.

Promoter Methylation and miRNA Regulation Are Major Factors of Protein Evolutionary Rates
-----------------------------------------------------------------------------------------

The above analyses indicated that both promoter and gene body methylation levels are important indicators of protein evolutionary rates (*d*~N~ and *d*~N~/*d*~S~). We next set out to determine which biological factor(s) is/are the major factor(s) of protein evolutionary rates. We previously reported that of the ten biological factors associated with evolutionary rates of proteins (*N*~TF~, *N*~miR~, protein connectivity, expression level, tissue specificity, UTR length, intron length, intron number, solvent accessibility, and disorder content), *N*~miR~ tends to be the most important factor of *d*~N~ and *d*~N~/*d*~S~ in mammals ([@evu124-B13]). We therefore estimated the relative importance of these ten factors and promoter/gene body methylation levels in determining the rate of mammalian protein evolution. Using partial correlation analysis, we examined the correlations between protein evolutionary rates and each of these 12 factors in turn by simultaneously controlling for the other 11 factors. As shown in [figure 3](#evu124-F3){ref-type="fig"}, we found that promoter mCG density and *N*~miR~ had the greatest influence on *d*~N~ and *d*~N~/*d*~S~ for both human--macaque and human--mouse comparisons. Gene body mCG density has a relatively lower effect on *d*~N~ and *d*~N~/*d*~S~ than promoter mCG density and *N*~miR~, but a relatively greater effect than *N*~TF~ ([fig. 3](#evu124-F3){ref-type="fig"}). We also performed a linear repression model, RCVE (see Materials and Methods), to measure the relative effect of these 12 factors in determining *d*~N~ and *d*~N~/*d*~S~, and showed the similar trends ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online). F[ig]{.smallcaps}. 3.---Absolute values of Spearman's rank correlation coefficients (*ρ*) between protein evolutionary rates (*d*~N~ and *d*~N~/*d*~S~) and one of the indicated factors (promoter/gene body mCG density \[mCG~p~ and mCG~g~\], *N*~TF~, *N*~miR~, protein connectivity \[PPI\], expression level \[ExpLvl\], tissue specificity \[*τ*\], UTR length \[UTR_L\], intron length \[In_L\], intron number \[InNum\], solvent accessibility \[SolAcc\], or disorder content \[DisCont\]), while simultaneously controlling for the other 11 factors, for both human--macaque (5,128 genes) and human--mouse (5,357 genes) orthologs.

As discussed above, promoter mCG density and *N*~miR~ have opposite effects on *d*~N~ and *d*~N~/*d*~S~. The finding that they are both the major factors of protein evolutionary rates thus raises the question of whether these two rate determinants have an interaction impact (especially mutual impact) on protein evolutionary rates. This will be discussed in the next section.

Promoter Methylation and miRNA Regulation Exhibit Dependent Effects on Protein Evolutionary Rates in Mammals
------------------------------------------------------------------------------------------------------------

Recent studies reported that promoter methylation and miRNA may coregulate their target genes. Changes in promoter methylation may affect miRNA targeting, suggesting a mutual correlation between miRNA-mediated regulation of target genes and miRNA-targeting-specific promoter methylation in brain ([@evu124-B71], [@evu124-B72]). Promoter methylation of miRNA-targeted genes has also been suggested to be highly correlated with miRNA seed region features ([@evu124-B72]). For example, the promoters of genes targeted by miR-548 tend to be significantly hypomethylated ([@evu124-B72]). [Figure 2](#evu124-F2){ref-type="fig"} also reveals a significantly negative correlation between mCG density and *N*~miR~. Therefore, we are curious about whether there is a dependent effect of promoter mCG density and *N*~miR~ on protein evolutionary rates. To this end, we conducted a stepwise multiple regression analysis including promoter and gene body mCG densities and the aforementioned ten biological factors to examine the interaction of the effects of these factors on *d*~N~/*d*~S~. The stepwise model selection showed that the coefficient of promoter mCG density--*N*~miR~ interaction terms significantly deviate from zero in both human--macaque and human--mouse comparisons ([supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online), suggesting the dependence between promoter methylation and miRNA regulations in determining *d*~N~/*d*~S~.

To further probe the interaction impact of promoter methylation and miRNA regulations on mammalian protein evolution, we divided the human protein-coding genes into five groups of similar size, according to the magnitudes of *d*~N~ or *d*~N~/*d*~S~, and calculated the median values of promoter mCG density and *N*~miR~ for each group of genes. As shown in [figure 4](#evu124-F4){ref-type="fig"}, the lower the promoter mCG density, the lower the *d*~N~ and *d*~N~/*d*~S~ values for both human--macaque and human--mouse comparisons; on the other hand, an opposite correlation was observed between *N*~miR~ and protein evolutionary rates. In other words, genes with hypomethylated promoters and strong miRNA regulation are subject to stringent selective constraints; in contrast, genes with hypermethylated promoters and weak miRNA regulation are subject to relaxed selective constraints. This result indicates that these two factors have a mutual impact on protein evolutionary rates, also reflecting the above observations that *d*~N~ and *d*~N~/*d*~S~ values are negatively correlated with *N*~miR~ but positively correlated with promoter mCG density ([table 2](#evu124-T2){ref-type="table"}). F[ig]{.smallcaps}. 4.---The median values of promoter mCG density (mCG~p~) and *N*~miR~ in five groups of human protein-coding genes of similar size (divided according to the magnitudes of *d*~N~ and *d*~N~/*d*~S~, from low to high) for both human--macaque (5,128 genes) and human--mouse (5,357 genes) comparisons.

Potential Caveats
-----------------

In this study, the single base-resolution methylome data were derived from cultured cells or cells from healthy individuals ([table 1](#evu124-T1){ref-type="table"}). It is possible that methylome data from cancerous cell lines may have introduced bias in the trends we observed. To examine this possibility, we extracted single base-resolution methylome data from breast cancer cells ([supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online) ([@evu124-B32]), and performed the same analyses as described above. We found the similar trends as described above: promoter methylation is positively correlated with protein evolutionary rates but negatively correlated with *N*~TF~ and *N*~miR~, whereas the opposite was observed for gene body methylation ([supplementary tables S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) and S5 and [fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online); the relative importance of these regulatory factors in determining the rate of mammalian protein evolution is as follows: promoter methylation ≈ miRNA regulation \> gene body methylation \> TF regulation ([supplementary fig. S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online); and promoter methylation and miRNA regulation have a significant dependent effect on protein evolutionary rates ([supplementary fig. S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) and [table S6](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) online). In addition, because rodents have a faster molecular clock than primates ([@evu124-B45]; [@evu124-B57]), it is possible that the observed trends may be biased toward the compared species with different molecular clocks. In this study, we performed all statistical analyses on both comparisons between primate and rodent (i.e., human vs. mouse) and those between primates (i.e., human vs. rhesus macaque), and showed that they had the same tendencies. We thus suggest that the observed trends are not biased toward different molecular clocks.

Conclusions
===========

In this study, we examined the impacts of promoter/gene body methylation, TF regulation, and miRNA regulation (which act before, during, and after transcription, respectively) on the evolutionary rates of the target protein-coding genes. We made several findings. First, promoter and gene body methylation levels exhibit opposite correlation patterns with protein evolutionary rates (*d*~N~ and *d*~N~/*d*~S~): the former exhibits a positive correlation with *d*~N~ and *d*~N~/*d*~S~, whereas the latter exhibits an inverse correlation with these two evolutionary rates ([table 2](#evu124-T2){ref-type="table"}). On the basis of partial correlation analysis, we emphasize that these correlations are maintained after excluding the effect of other confounding factors ([table 2](#evu124-T2){ref-type="table"}), indicating that both promoter and gene body methylation levels are important indicators of protein evolutionary rates of their target genes. We also demonstrated that protein evolutionary rates are more strongly correlated with promoter methylation level than with gene body methylation level. Second, promoter and gene body methylation levels also exhibit different correlation patterns with the two *trans*-regulations (*N*~TF~ and *N*~miR~); the former is negatively correlated with *N*~TF~ and *N*~miR~, whereas the latter is positively correlated with these *trans*-regulations ([fig. 2](#evu124-F2){ref-type="fig"}). Because *N*~TF~ and *N*~miR~ have been previously reported to be positively correlated with each other but inversely correlated with protein evolutionary rates ([@evu124-B13]), the correlations between promoter/gene body mCG density, *N*~TF~, *N*~miR~, and protein evolutionary rates can be summarized in [figure 5](#evu124-F5){ref-type="fig"}. Third, we established that the relative importance of these regulatory factors in determining the protein evolutionary rates is as follows: promoter mCG density ≈ *N*~miR~ \> gene body mCG density \> *N*~TF~. We further determined that, among the 12 biological factors considered, promoter methylation and miRNA regulation are generally the major factors in determining *d*~N~ and *d*~N~/*d*~S~. Finally, we demonstrated that these two factors have a dependent effect on protein evolutionary rates, and they have a mutual impact on protein evolutionary rates. In summary, our results indicate the complicated effects of natural selection on protein evolution, and the intricate relationships between regulatory systems acting before, during, and after transcription. This study thus increases our understanding of DNA methylation, TF, and miRNA regulations in evolutionary biology. F[ig]{.smallcaps}. 5.---The correlations between promoter and gene body mCG densities, *N*~TF~, *N*~miR~, and protein evolutionary rates (*d*~N~ and *d*~N~/*d*~S~). Solid and dotted lines represent positive and negative correlations, respectively.
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[Supplementary figures S1--S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) and [tables S1--S6](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu124/-/DC1) are available at *GenomeBiology and Evolution* online (<http://www.gbe.oxfordjournals.org/>).
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[^1]: **Associate editor:** Hidemi Watanabe

[^2]: ^a^Coverage of CpG dinucleotides for each promoter/gene body (protein-coding) region = (number of sampled CpG dinucleotides)/(number of sampled CpG dinucleotides + number of nonsampled CpG dinucleotides).

[^3]: N[ote]{.smallcaps}.---The ten confounding factors are *N*~TF~, *N*~miR~, protein connectivity, expression level, tissue specificity, UTR length, intron length, intron number, solvent accessibility, and disorder content.

[^4]: ^a^The analysis was based on 5,128 human genes and their macaque orthologs.

[^5]: ^b^The analysis was based on 5,357 human genes and their mouse orthologs.

[^6]: \**P*\< 0.05 and \*\*\**P* \< 0.001.
